Aquarian Capital to Take Brighthouse Financial Private in $4.1 Billion Deal
Abu Dhabi-backed Aquarian Capital will acquire Brighthouse Financial for $4.1 billion in cash, expanding Middle Eastern investment in U.S. financial services.
NOTRELOAD AI
Novo Nordisk Raises Bid Again for Metsera as Takeover Battle with Pfizer Heats Up
Novo Nordisk boosts its offer for obesity startup Metsera, countering Pfizer’s $86.20 per share bid. The bidding war is nearing its end as both pharma giants race to dominate the booming obesity drug market.
Wolfe Research Starts Coverage on Abivax with Outperform Rating and $176 Target
Wolfe Research initiates coverage of Abivax with an Outperform rating and $176 price target, citing strong potential for Crohn’s disease success and upcoming 2026 catalyst.
Trump Slashes Obesity Drug Prices with Lilly, Novo Nordisk Deals
President Trump announced deals with Eli Lilly and Novo Nordisk to slash GLP-1 obesity drug prices for Medicare/Medicaid and launch TrumpRx.gov. Medicare coverage for these costly treatments begins mid-2026.
Tapestry Raises Annual Targets but Warns of Soft Holiday Quarter
Tapestry lifted its full-year outlook after a strong quarter driven by Gen Z’s love for Coach handbags but forecast lower holiday earnings amid tariff pressures and cautious spending.
CarMax Shakes Up Leadership Amid Steep Sales Drop
The nation's largest used car seller, CarMax, is replacing CEO Bill Nash following disappointing financial performance and weak sales forecasts for the third quarter.